









Mercado
/
Acciones
/
nasdaq-ci
/

Cigna Group

279.120USD

-4.790-1.69%

Cierre 01/09, 16:00（ET）Cotizaciones retrasadas 15 min

74.41BCap. mercado

12.26P/E TTM



Cigna Group

279.120

-4.790-1.69%

Descripción general Compañía Finanzas Análisis

Descripción general

Compañía

Finanzas

Análisis

Más Datos de Cigna Group Compañía

The Cigna Group is a global health company. The Company has two growth platforms: Evernorth Health Services and Cigna Healthcare. Evernorth Health Services includes its Pharmacy Benefit Services and Specialty and Care Services operating segments, which provide independent and coordinated health solutions and capabilities to enable the healthcare system to work better and help people live richer, healthier lives. Cigna Healthcare includes the U.S. Healthcare and International Health operating segments, which provide comprehensive medical plan services and coordinated solutions to clients and customers. Its Other Operations include corporate-owned life insurance (COLI), the Company's run-off operations and other non-strategic businesses. Specialty and Care Services provides specialty drugs for the treatment of complex and rare diseases, specialty distribution of pharmaceuticals and medical supplies, and clinical programs to help its clients.

Información de Cigna Group



Símbolo de cotizaciónCI

Nombre de la empresaCigna Group

Fecha de salida a bolsaApr 01, 1982

Director ejecutivoCordani (David M)

Número de empleados73500

Tipo de seguridadOrdinary Share

Fin del año fiscalApr 01

Dirección900 Cottage Grove Road

CiudadBLOOMFIELD

Bolsa de valoresNASDAQ OMX NASDAQ Basic NYSE

PaísUnited States of America

Código postal06002

Teléfono18602266000

Sitio Webhttps://www.thecignagroup.com/

Símbolo de cotizaciónCI

Fecha de salida a bolsaApr 01, 1982

Director ejecutivoCordani (David M)

Ejecutivos de Cigna Group



Nombre

Nombre/Posición

Posición

Accionistas

Cambio

Mr. David M. Cordani, CPA

Chairman of the Board, Chief Executive Officer

667.15K

-26527.00%

Mr. Brian C. Evanko

President, Chief Operating Officer

65.23K

+901.00%

Mr. Eric C. Wiseman

Lead Independent Director

23.16K

+638.00%

Maj. Gen. (Retd.) Elder Granger, M.D.

Independent Director

6.11K

+638.00%

Ms. Kathleen M. Mazzarella

Independent Director

6.11K

+638.00%

Ms. Kimberly A. Ross

Independent Director

4.51K

+638.00%

Mr. George Kurian

Independent Director

3.78K

+638.00%

Ms. Neesha Hathi

Independent Director

3.37K

+638.00%

Ms. Ann M. Dennison

Chief Financial Officer, Executive Vice President

2.92K

+2920.00%

Mr. Eric J. Foss

Independent Director

Nombre

Nombre/Posición

Posición

Accionistas

Cambio

Mr. David M. Cordani, CPA

Chairman of the Board, Chief Executive Officer

667.15K

-26527.00%

Mr. Brian C. Evanko

President, Chief Operating Officer

65.23K

+901.00%

Mr. Eric C. Wiseman

Lead Independent Director

23.16K

+638.00%

Maj. Gen. (Retd.) Elder Granger, M.D.

Independent Director

6.11K

+638.00%

Ms. Kathleen M. Mazzarella

Independent Director

6.11K

+638.00%

Ms. Kimberly A. Ross

Independent Director

4.51K

+638.00%

Desglose de ingresos

Divisa: USDActualizado: mar., 6 de ene

FY2025Q3

FY2025Q2

FY2025Q1

FY2024

FY2024Q4

FY2024Q3

FY2024Q2

FY2024Q1

FY2023

FY2023Q4

FY2023Q3

FY2023Q2

FY2023Q1

FY2022

FY2022Q4

FY2022Q3

FY2022Q2

FY2021

FY2018

Por negocioUSD

Nombre

Ganancia

Proporción

Pharmacy revenues

56.05B

80.37%

Premiums

9.08B

13.02%

Fees and other revenues

4.38B

6.28%

Other revenues

233.00M

0.33%

La empresa aún no ha revelado los datos relevantes.

Por negocio

Por región

Por negocioUSD

Nombre

Ganancia

Proporción

Pharmacy revenues

56.05B

80.37%

Premiums

9.08B

13.02%

Fees and other revenues

4.38B

6.28%

Other revenues

233.00M

0.33%

Estadísticas de accionistas

Actualizado: vie., 9 de ene

Accionistas

Tipos de accionistas

Accionistas

Proporción

The Vanguard Group, Inc.

9.59%

BlackRock Institutional Trust Company, N.A.

4.73%

State Street Investment Management (US)

4.54%

T. Rowe Price Associates, Inc.

4.08%

MFS Investment Management

3.95%

Otro

73.11%

Accionistas

Proporción

The Vanguard Group, Inc.

9.59%

BlackRock Institutional Trust Company, N.A.

4.73%

State Street Investment Management (US)

4.54%

T. Rowe Price Associates, Inc.

4.08%

MFS Investment Management

3.95%

Otro

73.11%

Tipos de accionistas

Accionistas

Proporción

Investment Advisor

52.70%

Investment Advisor/Hedge Fund

28.38%

Research Firm

2.55%

Pension Fund

2.25%

Bank and Trust

1.71%

Hedge Fund

1.58%

Sovereign Wealth Fund

1.39%

Corporation

1.19%

Individual Investor

0.39%

Otro

7.85%

Participación institucional



Actualizado: lun., 8 de dic

Periodo del informe

Número de instituciones

Acciones mantenidas

Proporción

Cambio

2025Q4

2912

241.71M

90.49%

-1.82M

2025Q3

2972

242.12M

91.90%

+1.54M

2025Q2

2981

240.55M

93.84%

-5.16M

2025Q1

2971

246.39M

94.63%

-8.92M

2024Q4

2988

249.03M

93.14%

+458.77K

2024Q3

2914

248.98M

92.53%

-1.29M

2024Q2

2894

250.44M

95.06%

-5.89M

2024Q1

2849

256.08M

92.56%

-14.53M

2023Q4

2795

262.30M

92.80%

-573.37K

2023Q3

2699

263.15M

93.94%

-4.31M

Actividad de los accionistas



Nombre

Acciones mantenidas

Proporción

Cambio

Cambio %

Fecha

The Vanguard Group, Inc.

25.62M

9.59%

+27.96K

+0.11%

Sep 30, 2025

BlackRock Institutional Trust Company, N.A.

12.64M

4.73%

+229.62K

+1.85%

Sep 30, 2025

State Street Investment Management (US)

12.12M

4.54%

-145.49K

-1.19%

Sep 30, 2025

T. Rowe Price Associates, Inc.

10.90M

4.08%

+1.00M

+10.12%

Sep 30, 2025

MFS Investment Management

10.55M

3.95%

-863.89K

-7.57%

Sep 30, 2025

Dodge & Cox

9.31M

3.48%

+354.62K

+3.96%

Sep 30, 2025

Fidelity Management & Research Company LLC

8.27M

3.1%

-538.79K

-6.12%

Sep 30, 2025

Sanders Capital, LLC

7.83M

2.93%

+35.15K

+0.45%

Sep 30, 2025

GQG Partners, LLC

6.79M

2.54%

+1.02M

+17.70%

Sep 30, 2025

Geode Capital Management, L.L.C.

6.00M

2.25%

+39.79K

+0.67%

Sep 30, 2025

ETFs relacionados



Actualizado: sáb., 6 de dic

Nombre

Proporción

iShares U.S. Healthcare Providers ETF

7.92%

VictoryShares Free Cash Flow ETF

3.31%

Invesco Dynamic Buyback Achievers ETF

3.22%

Monarch Dividend Plus Index ETF

2.79%

TrueShares Low Volatility Equity Income ETF

2.58%

Hennessy Sustainable ETF

2.3%

VictoryShares US Multi-Factor Minimum Vol ETF

2.16%

Brandes US Value ETF

1.9%

Bushido Capital US Equity ETF

1.89%

Davis Select US Equity ETF

1.86%

iShares U.S. Healthcare Providers ETF

Proporción7.92%

VictoryShares Free Cash Flow ETF

Proporción3.31%

Invesco Dynamic Buyback Achievers ETF

Proporción3.22%

Monarch Dividend Plus Index ETF

Proporción2.79%

TrueShares Low Volatility Equity Income ETF

Proporción2.58%

Hennessy Sustainable ETF

Proporción2.3%

VictoryShares US Multi-Factor Minimum Vol ETF

Proporción2.16%

Brandes US Value ETF

Proporción1.9%

Bushido Capital US Equity ETF

Proporción1.89%

Davis Select US Equity ETF

Proporción1.86%

Dividendos



Un total de 5.74B USD se ha distribuido en dividendos durante los últimos 5 años.

Fecha

Dividendos

Fecha de registro

Fecha de pago

Fecha ex-dividendo

Oct 22, 2025

CI.NB Final Cash Dividend of gross USD 1.51 paid on Dec 18, 2025 going ex on Dec 04, 2025 with reinvestment option

Dec 04, 2025

Dec 18, 2025

Dec 04, 2025

Jul 22, 2025

CI.NB Interim Cash Dividend of gross USD 1.51 paid on Sep 18, 2025 going ex on Sep 04, 2025 with reinvestment option

Sep 04, 2025

Sep 18, 2025

Sep 04, 2025

Apr 23, 2025

CI.NB Interim Cash Dividend of gross USD 1.51 paid on Jun 18, 2025 going ex on Jun 03, 2025 with reinvestment option

Jun 03, 2025

Jun 18, 2025

Jun 03, 2025

Jan 30, 2025

CI.NB Interim Cash Dividend of gross USD 1.51 paid on Mar 20, 2025 going ex on Mar 05, 2025 with reinvestment option

Mar 05, 2025

Mar 20, 2025

Mar 05, 2025

Oct 23, 2024

CI.NB Final Cash Dividend of gross USD 1.4 paid on Dec 19, 2024 going ex on Dec 04, 2024 with reinvestment option

Dec 04, 2024

Dec 19, 2024

Dec 04, 2024

Oct 23, 2024

CI.NB Final Cash Dividend of gross USD 1.4 paid on Dec 19, 2024 going ex on Dec 04, 2024

Dec 04, 2024

Dec 19, 2024

Dec 04, 2024

Jul 24, 2024

CI.NB Interim Cash Dividend of gross USD 1.4 paid on Sep 19, 2024 going ex on Sep 04, 2024 with reinvestment option

Sep 04, 2024

Sep 19, 2024

Sep 04, 2024

Apr 24, 2024

CI.NB Interim Cash Dividend of gross USD 1.4 paid on Jun 20, 2024 going ex on Jun 04, 2024 with reinvestment option

Jun 04, 2024

Jun 20, 2024

Jun 04, 2024

Feb 02, 2024

CI.NB Interim Cash Dividend of gross USD 1.4 paid on Mar 21, 2024 going ex on Mar 05, 2024 with reinvestment option

Mar 06, 2024

Mar 21, 2024

Mar 05, 2024

Oct 25, 2023

CI.NB Final Cash Dividend of gross USD 1.23 paid on Dec 21, 2023 going ex on Dec 05, 2023

Dec 06, 2023

Dec 21, 2023

Dec 05, 2023

División de acciones



Fecha

Tipo

Relación

Sin datos

Fecha

Tipo

Relación

Sin datos

Preguntas frecuentes

¿Quiénes son los cinco principales accionistas de Cigna Group?



Los cinco principales accionistas de Cigna Group son:
The Vanguard Group, Inc. posee 25.62M acciones, lo que representa el 9.59% del total de acciones.
BlackRock Institutional Trust Company, N.A. posee 12.64M acciones, lo que representa el 4.73% del total de acciones.
State Street Investment Management (US) posee 12.12M acciones, lo que representa el 4.54% del total de acciones.
T. Rowe Price Associates, Inc. posee 10.90M acciones, lo que representa el 4.08% del total de acciones.
MFS Investment Management posee 10.55M acciones, lo que representa el 3.95% del total de acciones.

¿Cuáles son los tres principales tipos de accionista de Cigna Group?



Los tres principales tipos de accionista de Cigna Group son:
The Vanguard Group, Inc.
BlackRock Institutional Trust Company, N.A.
State Street Investment Management (US)

¿Cuántas instituciones poseen acciones de Cigna Group (CI)?



A fecha de 2025Q4, 2912 instituciones poseen acciones de Cigna Group, con un valor de mercado combinado de aproximadamente 241.71M, lo que representa el 90.49% del total de acciones. En comparación con el 2025Q3, el accionariado institucional ha aumentado en -1.41%.

¿Cuál es la mayor fuente de ganancias de Cigna Group?



El FY2025Q3, el segmento empresarial Pharmacy revenues generó la ganancia más alta para Cigna Group, ascendiendo a 56.05B y representando el 80.37% de la ganancia total.

KeyAI

